DMW - Deutsche Medizinische Wochenschrift, Table of Contents Dtsch Med Wochenschr 2024; 149(06): 268-269DOI: 10.1055/a-2171-5263 Aktuell publiziert Kommentar zu „Cannabis-Therapien zeigen je nach Patientengruppe deutliche Vor- und Nachteile“ Contributor(s): Peter Neu Recommend Article Abstract Buy Article Comment on: Cannabis-Therapien zeigen je nach Patientengruppe deutliche Vor- und NachteileDtsch Med Wochenschr 2024; 149(06): 268-268DOI: 10.1055/a-2171-5230 Full Text References Literatur 1 Fusar-Poli P, Radua J. Ten simple rules for conducting umbrella reviews. Evid Based Ment Health 2018; 21 (03) 95-100 2 Cerdá M, Kilmer B. Uruguay’s middle-ground approach to cannabis legalization. Int J Drug Policy 2017; 42: 118-120 3 Government of Canada. Cannabis Act. Ottawa: Department of Justice. 2018 4 Hall W, Linskey M. Assessing the public health impacts of legalizing recreational cannabis use: the US experience. World Psychiatry 2020; 19 (02) 179-186 5 Wolfe D, Corace K, Butler C. et al. Impacts of medical and non-medical cannabis on the health of older adults: Findings from a scoping review of the literature. Review PLoS One 2023 17;18(02):e0281826. .
